Iron–Dextran (Highly Pure)

Product Description

Iron–Dextran (Highly Pure)
Catalog number: B2018982
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 10 g
Molecular Weight or Concentration: N/A
Supplied as: Powder
Applications: a molecular tool for various biochemical applications
Storage: RT
Keywords: IRON DEXTRAN|9004-66-4|Sulfuric acid, iron salt|iron;sulfuric acid|Fero Gradumet|Iron-Dextran|Sulfuric acid, iron(3+) salt (3:2)|Conferon|10124-49-9|Sulfuric acid iron(2+) salt (1:1)|WLN: FE S-O4|Sulphuric acid, iron salt|Fe dextran|Sulfuric acid, iron sa
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1: Auerbach M, Adamson JW. How we diagnose and treat iron deficiency anemia Am J Hematol. 2016 Jan;91(1):31-8.
2: Auerbach M, Pappadakis JA, Bahrain H, Auerbach SA, Ballard H, Dahl NV. Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemia Am J Hematol. 2011 Oct;86(10):860-2.
3: Zou P, Tyner K, Raw A, Lee S. Physicochemical Characterization of Iron Carbohydrate Colloid Drug Products AAPS J. 2017 Sep;19(5):1359-1376.
4: Kumpf VJ, Holland EG. Parenteral iron dextran therapy DICP. 1990 Feb;24(2):162-6.
5: Silverstein SB, Rodgers GM. Parenteral iron therapy options Am J Hematol. 2004 May;76(1):74-8.
6: Total dose iron infusion Nutr Rev. 1969 Jul;27(7):193-6.
7: Littlewood TJ. Intravenous or oral iron? Am J Hematol. 2012 Feb;87(2):134-5.
8: Koepke JA. Iron-deficiency anemia Postgrad Med. 1972 Jun;51(7):163-7.
9: Auerbach M, Rodgers GM. Intravenous iron N Engl J Med. 2007 Jul 5;357(1):93-4.
10: Burns DL, Pomposelli JJ. Toxicity of parenteral iron dextran therapy Kidney Int Suppl. 1999 Mar;69:S119-24.

Products Related to Iron–Dextran (Highly Pure) can be found at Chemicals